Earnings Feed
Start Free
Home/Filings/3/0001062993-21-004263
3//SEC Filing

SIMONS JAMES H 3

Accession 0001062993-21-004263

CIK 0001699382other
View on SEC.govCompany Profile

Filed

May 6, 8:00 PM ET

Accepted

May 7, 4:51 PM ET

Size

20.7 KB

Accession

0001062993-21-004263

Insider Transaction Report

Form 3
Period: 2021-04-28
PMV Pharmaceuticals, Inc.PMVP
Euclidean Capital LLC
Other
Holdings

  • Common Stock

    (indirect: See footnotes)
    2,601,637

  • Common Stock

    (indirect: See footnotes)
    132,601

  • Common Stock

    (indirect: See footnotes)
    494,407

  • Common Stock

    (indirect: See footnotes)
    693,769

  • Common Stock

    (indirect: See footnotes)
    751,409
Greenland A LLC
Other
Holdings

  • Common Stock

    (indirect: See footnotes)
    693,769

  • Common Stock

    (indirect: See footnotes)
    751,409

  • Common Stock

    (indirect: See footnotes)
    2,601,637

  • Common Stock

    (indirect: See footnotes)
    132,601

  • Common Stock

    (indirect: See footnotes)
    494,407
Greenland FP LLC
Other
Holdings

  • Common Stock

    (indirect: See footnotes)
    693,769

  • Common Stock

    (indirect: See footnotes)
    2,601,637

  • Common Stock

    (indirect: See footnotes)
    132,601

  • Common Stock

    (indirect: See footnotes)
    751,409

  • Common Stock

    (indirect: See footnotes)
    494,407
Chhabra Ashvin
Other
Holdings

  • Common Stock

    (indirect: See footnotes)
    2,601,637

  • Common Stock

    (indirect: See footnotes)
    132,601

  • Common Stock

    (indirect: See footnotes)
    693,769

  • Common Stock

    (indirect: See footnotes)
    751,409

  • Common Stock

    (indirect: See footnotes)
    494,407
Greenland NFP LLC
Other
Holdings

  • Common Stock

    (indirect: See footnotes)
    494,407

  • Common Stock

    (indirect: See footnotes)
    693,769

  • Common Stock

    (indirect: See footnotes)
    2,601,637

  • Common Stock

    (indirect: See footnotes)
    751,409

  • Common Stock

    (indirect: See footnotes)
    132,601
Simons Marilyn
Other
Holdings

  • Common Stock

    (indirect: See footnotes)
    751,409

  • Common Stock

    (indirect: See footnotes)
    494,407

  • Common Stock

    (indirect: See footnotes)
    693,769

  • Common Stock

    (indirect: See footnotes)
    2,601,637

  • Common Stock

    (indirect: See footnotes)
    132,601
Greenland NFP B Ltd.
Other
Holdings

  • Common Stock

    (indirect: See footnotes)
    693,769

  • Common Stock

    (indirect: See footnotes)
    2,601,637

  • Common Stock

    (indirect: See footnotes)
    751,409

  • Common Stock

    (indirect: See footnotes)
    132,601

  • Common Stock

    (indirect: See footnotes)
    494,407
Symmetry Group Ltd.
10% Owner
Holdings

  • Common Stock

    (indirect: See footnotes)
    693,769

  • Common Stock

    (indirect: See footnotes)
    2,601,637

  • Common Stock

    (indirect: See footnotes)
    751,409

  • Common Stock

    (indirect: See footnotes)
    132,601

  • Common Stock

    (indirect: See footnotes)
    494,407
SIMONS JAMES H
Other
Holdings

  • Common Stock

    (indirect: See footnotes)
    2,601,637

  • Common Stock

    (indirect: See footnotes)
    132,601

  • Common Stock

    (indirect: See footnotes)
    693,769

  • Common Stock

    (indirect: See footnotes)
    751,409

  • Common Stock

    (indirect: See footnotes)
    494,407
Footnotes (6)
  • [F1]The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Marilyn Simons and James Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean.
  • [F2]The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean.
  • [F3]The shares are held of record by Greenland FP LLC, which is managed by Euclidean.
  • [F4]The shares are held of record by Greenland NFP LLC, which is managed by Euclidean.
  • [F5]The shares are held of record by Symmetry Group Ltd ("Symmetry"). Mrs. Simons and Mr. Simons are on the board of directors of Symmetry's parent.
  • [F6]Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein.

Documents

1 file

Issuer

PMV Pharmaceuticals, Inc.

CIK 0001699382

→
Entity typeother
IncorporatedNY

Related Parties

1
  • filerCIK 0000941976

Filing Metadata

Form type
3
Filed
May 6, 8:00 PM ET
Accepted
May 7, 4:51 PM ET
Size
20.7 KB
View on SEC.gov